Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014, Article ID 593562, 10 pages
http://dx.doi.org/10.1155/2014/593562
Research Article

Tumor-Activated T Cells from Gastric Cancer Patients Induce the Antitumor Immune Response of T Cells via Their Antigen-Presenting Cell-Like Effects

1Department of Nuclear Medicine, The Affiliated Hospital of Jiangsu University, 438 Jiefang Road, Zhenjiang 212001, China
2Institute of Oncology, The Affiliated Hospital to Jiangsu University, 438 Jiefang Road, Zhenjiang 212001, China
3Department of Immunology and Laboratory Immunology, School of Medical Science and Laboratory Medicine, Jiangsu University, 301 Xuefu Road, Zhenjiang 212013, China

Received 5 December 2013; Revised 28 January 2014; Accepted 25 February 2014; Published 31 March 2014

Academic Editor: Bin Zhang

Copyright © 2014 Chaoming Mao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. C. Ribot, A. DeBarros, and B. Silva-Santos, “Searching for “signal 2”: costimulation requirements of γδ T cells,” Cellular and Molecular Life Sciences, vol. 68, no. 14, pp. 2345–2355, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Q. Gomes, D. S. Martins, and B. Silva-Santos, “Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application,” Cancer Research, vol. 70, no. 24, pp. 10024–10027, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Kabelitz, D. Wesch, and W. He, “Perspectives of γδ T cells in tumor immunology,” Cancer Research, vol. 67, no. 1, pp. 5–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. Z. Liu, I. E. Eltoum, B. Guo, B. H. Beck, G. A. Cloud, and R. D. Lopez, “Protective immunosurveillance and therapeutic antitumor activity of γδ T cells demonstrated in a mouse model of prostate cancer,” Journal of Immunology, vol. 180, no. 9, pp. 6044–6053, 2008. View at Google Scholar · View at Scopus
  5. S. E. Street, Y. Hayakawa, Y. Zhan et al., “Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and γδ T cells,” Journal of Experimental Medicine, vol. 199, no. 6, pp. 879–884, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Girardi, D. E. Oppenheim, C. R. Steele et al., “Regulation of cutaneous malignancy by γδ T cells,” Science, vol. 294, no. 5542, pp. 605–609, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Hannani, Y. Ma, T. Yamazaki, J. Déchanet-Merville, G. Kroemer, and L. Zitvogel, “Harnessing γδ T cells in anticancer immunotherapy,” Trends in Immunology, vol. 33, no. 5, pp. 199–206, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H. J. Gober, M. Kistowska, L. Angman, P. Jenö, L. Mori, and G. de Libero, “Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells,” Journal of Experimental Medicine, vol. 197, no. 2, pp. 163–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. T. Morita, C. Jin, G. Sarikonda, and H. Wang, “Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vγ2Vδ2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens,” Immunological Reviews, vol. 215, no. 1, pp. 59–76, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Anderson, K. Gustafsson, and N. Himoudi, “Licensing of killer dendritic cells in mouse and humans: functional similarities between IKDC and human blood gammadelta T-lymphocytes,” Journal of Immunotoxicology, vol. 9, no. 3, pp. 259–266, 2012. View at Publisher · View at Google Scholar
  11. M. Brandes, K. Willimann, and B. Moser, “Professional antigen-presentation function by human γδ cells,” Science, vol. 309, no. 5732, pp. 264–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Himoudi, D. A. Morgenstern, M. Yan et al., “Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells,” Journal of Immunology, vol. 188, no. 4, pp. 1708–1716, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. L. Modlin and P. A. Sieling, “Now presenting: γδ T cells,” Science, vol. 309, no. 5732, pp. 252–253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Nakajima, T. Murakawa, T. Fukami et al., “A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells,” European Journal of Cardio-Thoracic Surgery, vol. 37, no. 5, pp. 1191–1197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Dokouhaki, M. Han, B. Joe et al., “Adoptive immunotherapy of cancer using ex vivo expanded human gammadelta T cells: a new approach,” Cancer Letters, vol. 297, no. 1, pp. 126–136, 2010. View at Publisher · View at Google Scholar
  16. M. Corvaisier, A. Moreau-Aubry, E. Diez et al., “V γ 9V δ 2 T cell response to colon carcinoma cells,” Journal of Immunology, vol. 175, no. 8, pp. 5481–5488, 2005. View at Google Scholar
  17. M. Todaro, M. D'Asaro, N. Caccamo et al., “Efficient killing of human colon cancer stem cells by γδ T lymphocytes,” Journal of Immunology, vol. 182, no. 11, pp. 7287–7296, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Peng, H. Y. Wang, W. Peng, Y. Kiniwa, K. H. Seo, and R. Wang, “Tumor-infiltrating γδ T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway,” Immunity, vol. 27, no. 2, pp. 334–348, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Gertner, A. Wiedemann, M. Poupot, and J. J. Fournié, “Human γδ T lymphocytes strip and kill tumor cells simultaneously,” Immunology Letters, vol. 110, no. 1, pp. 42–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Mao, S. Wang, Q. Jiang et al., “Increased CD4+CD25+FOXP3+ regulatory T cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors,” Onkologie, vol. 31, no. 5, pp. 243–248, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Brandes, K. Willimann, G. Bioley et al., “Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 7, pp. 2307–2312, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Shojaei, H. H. Oberg, M. Juricke et al., “Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human γσ T cells,” Cancer Research, vol. 69, no. 22, pp. 8710–8717, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Li, M. Mandai, J. Hamanishi et al., “Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis,” Cancer Immunology, Immunotherapy, vol. 58, no. 5, pp. 641–652, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. X. M. Chen, X. Q. Xu, K. Sun, W. H. D. Hallett, J. D. Zhao, and D. L. Zhang, “NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells,” Scandinavian Journal of Immunology, vol. 67, no. 5, pp. 441–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Cosman, J. Müllberg, C. L. Sutherland et al., “ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor,” Immunity, vol. 14, no. 2, pp. 123–133, 2001. View at Google Scholar · View at Scopus
  26. K. Eleme, S. B. Taner, B. Önfelt et al., “Cell surface organization of stress-inducible proteins ULBP and MICA that stimulate human NK cells and T cells via NKG2D,” Journal of Experimental Medicine, vol. 199, no. 7, pp. 1005–1010, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Meuter, M. Eberl, and B. Moser, “Prolonged antigen survival and cytosolic export in cross-presenting human γδ T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 19, pp. 8730–8735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Vantourout and A. Hayday, “Six-of-the-best: unique contributions of gammadelta T cells to immunology,” Nature Reviews Immunology, vol. 13, no. 2, pp. 88–100, 2013. View at Publisher · View at Google Scholar
  29. C. H. June, B. R. Blazar, and J. L. Riley, “Engineering lymphocyte subsets: tools, trials and tribulations,” Nature Reviews Immunology, vol. 9, no. 10, pp. 704–716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ferrarini, E. Ferrero, L. Dagna, A. Poggi, and M. R. Zocchi, “Human γδ T cells: a nonredundant system in the immune-surveillance against cancer,” Trends in Immunology, vol. 23, no. 1, pp. 14–18, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Dieli, D. Vermijlen, F. Fulfaro et al., “Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer,” Cancer Research, vol. 67, no. 15, pp. 7450–7457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Lanca, M. F. Costa, N. Goncalves-Sousa et al., “Protective role of the inflammatory CCR2/CCL2 chemokine pathway through recruitment of type 1 cytotoxic γδ T lymphocytes to tumor beds,” Journal of Immunology, vol. 190, no. 12, pp. 6673–6680, 2013. View at Publisher · View at Google Scholar
  33. V. L. Green, A. Michno, N. D. Stafford, and J. Greenman, “Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity,” Cancer Immunology, Immunotherapy, vol. 62, no. 5, pp. 863–873, 2013. View at Publisher · View at Google Scholar
  34. Y. Yi, H. W. He, J. X. Wang et al., “The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner,” Journal of Hepatology, vol. 58, pp. 977–983, 2013. View at Publisher · View at Google Scholar
  35. L. Li and C. Wu, “CD4+CD25+ Treg cells inhibit human memory γδ T cells to produce IFN-γ in response to M tuberculosis antigen ES AT-6,” Blood, vol. 111, no. 12, pp. 5629–5636, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Ma, Q. Zhang, J. Ye et al., “Tumor-infiltrating gammadelta T lymphocytes predict clinical outcome in human breast cancer,” Journal of Immunology, vol. 189, no. 10, pp. 5029–5036, 2012. View at Publisher · View at Google Scholar
  37. D. Pende, P. Rivera, S. Marcenaro et al., “Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity,” Cancer Research, vol. 62, no. 21, pp. 6178–6186, 2002. View at Google Scholar · View at Scopus
  38. J. Qi, J. Zhang, S. Zhang, L. Cui, and W. He, “Immobilized MICA could expand human Vδ1 γδ T cells in vitro that displayed major histocompatibility complex class I chain-related A-dependent cytotoxicity to human epithelial carcinomas,” Scandinavian Journal of Immunology, vol. 58, no. 2, pp. 211–220, 2003. View at Publisher · View at Google Scholar · View at Scopus